Legal Representation
Attorney
Anthony P. Venturino
USPTO Deadlines
Next Renewal Deadline
1305 days remaining
Section 8 & 9 (30-Year) Renewal Due (Based on registration date 1999-02-02)
Due Date
February 02, 2029
Grace Period Ends
August 02, 2029
Application History
24 eventsDate | Code | Type | Description |
---|---|---|---|
Mar 2, 2019 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
Mar 2, 2019 | 89AG | O | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
Mar 2, 2019 | RNL2 | Q | REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS) |
Mar 2, 2019 | NA89 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED |
Jan 29, 2019 | E89R | I | TEAS SECTION 8 & 9 RECEIVED |
Mar 12, 2009 | PLGL | A | ASSIGNED TO PARALEGAL |
Mar 12, 2009 | 8PRT | O | REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED |
Mar 12, 2009 | 9G8P | O | REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8 |
Mar 12, 2009 | RNL1 | Q | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) |
Feb 2, 2009 | E89R | I | TEAS SECTION 8 & 9 RECEIVED |
Feb 2, 2009 | 89AF | I | REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED |
Feb 25, 2005 | C15A | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
Dec 7, 2004 | I | PAPER RECEIVED | |
Dec 7, 2004 | 815F | I | REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED |
Feb 2, 1999 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
Dec 17, 1998 | IUCN | S | NOTICE OF ALLOWANCE CANCELLED |
Dec 17, 1998 | 1.BD | I | Sec. 1(B) CLAIM DELETED |
Dec 1, 1998 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT |
Sep 8, 1998 | PUBO | A | PUBLISHED FOR OPPOSITION |
Aug 7, 1998 | NPUB | O | NOTICE OF PUBLICATION |
Jun 22, 1998 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
Jun 21, 1998 | DOCK | D | ASSIGNED TO EXAMINER |
Jun 21, 1998 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
Jun 21, 1998 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
Detailed Classifications
Class 001
[ chemical used in the manufacture of pharmaceuticals ]
First Use Anywhere:
0
First Use in Commerce:
0
Class 005
Pharmaceutical preparations [for curing cardiovascular disorders; anti-inflammatory and anti-rheumatic drugs, drugs for the central nervous system,] for the respiratory system [ and for skin diseases; pharmaceutical preparations for curing alimentary tract and metabolism problems; genito urinary system preparations anti-infectives, immunomodulators, hematological agents and otologicals ]
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
001
005